AU7491800A - Immunotherapy with substantially human polyclonal antibody preparations purifiedfrom genetically engineered birds - Google Patents

Immunotherapy with substantially human polyclonal antibody preparations purifiedfrom genetically engineered birds

Info

Publication number
AU7491800A
AU7491800A AU74918/00A AU7491800A AU7491800A AU 7491800 A AU7491800 A AU 7491800A AU 74918/00 A AU74918/00 A AU 74918/00A AU 7491800 A AU7491800 A AU 7491800A AU 7491800 A AU7491800 A AU 7491800A
Authority
AU
Australia
Prior art keywords
purifiedfrom
immunotherapy
birds
genetically engineered
polyclonal antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU74918/00A
Inventor
Jens-Ulrich Buelow
Wim Van Schooten
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Therapeutic Human Polyclonals Inc
Original Assignee
Therapeutic Human Polyclonals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therapeutic Human Polyclonals Inc filed Critical Therapeutic Human Polyclonals Inc
Publication of AU7491800A publication Critical patent/AU7491800A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/082—Hepadnaviridae, e.g. hepatitis B virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU74918/00A 1999-09-15 2000-09-15 Immunotherapy with substantially human polyclonal antibody preparations purifiedfrom genetically engineered birds Abandoned AU7491800A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15420099P 1999-09-15 1999-09-15
US60154200 1999-09-15
PCT/US2000/025369 WO2001019394A2 (en) 1999-09-15 2000-09-15 Immunotherapy with substantially human polyclonal antibody preparations purified from genetically engineered birds

Publications (1)

Publication Number Publication Date
AU7491800A true AU7491800A (en) 2001-04-17

Family

ID=22550402

Family Applications (1)

Application Number Title Priority Date Filing Date
AU74918/00A Abandoned AU7491800A (en) 1999-09-15 2000-09-15 Immunotherapy with substantially human polyclonal antibody preparations purifiedfrom genetically engineered birds

Country Status (2)

Country Link
AU (1) AU7491800A (en)
WO (1) WO2001019394A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001284703B2 (en) 2000-08-03 2007-03-22 Therapeutic Human Polyclonals Inc. Production of humanized antibodies in transgenic animals
US20050144655A1 (en) 2000-10-31 2005-06-30 Economides Aris N. Methods of modifying eukaryotic cells
US6596541B2 (en) 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
JP2002316944A (en) * 2001-04-17 2002-10-31 Chemo Sero Therapeut Res Inst Human polyclonal antibody composition
CA2965865C (en) 2002-07-18 2021-10-19 Merus N.V. Recombinant production of mixtures of antibodies
USRE47770E1 (en) 2002-07-18 2019-12-17 Merus N.V. Recombinant production of mixtures of antibodies
US20100069614A1 (en) 2008-06-27 2010-03-18 Merus B.V. Antibody producing non-human mammals
EP2395016A3 (en) 2003-05-30 2012-12-19 Merus B.V. Design and use of paired variable regions of specific binding molecules
MXPA06000562A (en) 2003-07-15 2006-03-30 Therapeutic Human Polyclonals Humanized immunoglobulin loci.
DK1737971T3 (en) 2004-01-20 2017-11-13 Merus Nv MIXTURES OF BINDING PROTEINS
JP5087625B2 (en) 2006-09-01 2012-12-05 セラピューティック・ヒューマン・ポリクローナルズ・インコーポレーテッド Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals
EP2183381A1 (en) * 2007-06-01 2010-05-12 Buelow Research Enterprises Llc Compositions and methods for producing antibodies having human idiotypes in transgenic birds
JPWO2009142186A1 (en) * 2008-05-20 2011-09-29 株式会社カネカ Cytotoxic composition
WO2012122512A1 (en) 2011-03-10 2012-09-13 Hco Antibody, Inc. Recombinant production of mixtures of single chain antibodies
AU2013249985B2 (en) 2012-04-20 2017-11-23 Merus N.V. Methods and means for the production of Ig-like molecules
CN110283779A (en) * 2019-07-17 2019-09-27 吉林省农业科学院 A kind of isolated culture method and culture medium of chicken embryonic stem cells

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6300129B1 (en) * 1990-08-29 2001-10-09 Genpharm International Transgenic non-human animals for producing heterologous antibodies
ATE288484T1 (en) * 1991-11-14 2005-02-15 Charles Weissmann TRANSGENIC NON-HUMAN ANIMALS WITHOUT PRION PROTEIN
US5340740A (en) * 1992-05-15 1994-08-23 North Carolina State University Method of producing an avian embryonic stem cell culture and the avian embryonic stem cell culture produced by the process
JPH08509612A (en) * 1993-04-26 1996-10-15 ジェンファーム インターナショナル インコーポレイテッド Transgenic non-human animal capable of producing heterologous antibody
US6143559A (en) * 1996-11-18 2000-11-07 Arch Development Corporation Methods for the production of chicken monoclonal antibodies
KR20080059467A (en) * 1996-12-03 2008-06-27 아브게닉스, 인크. Transgenic mammals having human ig loci including plural vh and vk regions and antibodies produced therefrom
JP2003517261A (en) * 1997-08-04 2003-05-27 ユニバシティ オブ マサチューセッツ、ア パブリック インスチチユーション オブ ハイアー エデュケイション オブ ザ コモンウエルス オブ マサチューセッツ、アズ リプリゼンテッド バイ イッツ アマースト キャンパス Production of avian embryonic germ (EG) cell lines by long-term culture of PGCs, their use for cloning and chimera formation
ES2357495T3 (en) * 1997-10-16 2011-04-27 University Of Georgia Research Foundation, Inc. TRANSGENIC BIRDS AND PROTEIN PRODUCTION.
DK1151010T3 (en) * 1999-02-05 2006-01-09 Therapeutic Human Polyclonals Human polyclonal antibodies from antigenic non-human animals

Also Published As

Publication number Publication date
WO2001019394A2 (en) 2001-03-22
WO2001019394A3 (en) 2001-10-04

Similar Documents

Publication Publication Date Title
AU7491800A (en) Immunotherapy with substantially human polyclonal antibody preparations purifiedfrom genetically engineered birds
AU1462300A (en) Human pan-hcv human monoclonal antibodies
AU1290001A (en) Antibodies
AU1951201A (en) Peptide antigens
ZA9710409B (en) Stable lyophilised pharmaceutical preparations comprising mono- or polyclonal antibodies
EP1073464A4 (en) Monoclonal antibodies with reduced immunogenicity
IS2798B (en) Cloned human antibodies against CTLA-4
EE200000470A (en) Human anti-CD40 antibodies
AU4935000A (en) Antibodies
NO20015859D0 (en) Β-beta beta peptide preparations and methods for their preparation
AU2002220843A1 (en) Humanised antibodies and uses thereof
AU2001256325A1 (en) Human and humanized fap-alpha-specific antibodies
AU4139801A (en) Controlled delivery of antigens
AU7676300A (en) Human anti-adipocyte monoclonal antibodies and their use
AU5992999A (en) Tumor antigens and ctl clones isolated by a novel procedure
AU5441000A (en) Human monoclonal antibody
AU5744200A (en) Human transport proteins
IL206565A0 (en) An antibody immunospecific for an igs4 polypeptide
AU2452301A (en) Protein methylarginine-specific antibodies
AU4483500A (en) Human membrane-associated proteins
AU2003244237A1 (en) Monoclonal antibody against adiponectin, preparation method and use thereof
AU2001245552A1 (en) Transcutaneous immunization for large particulate antigens
AU6227800A (en) Recombinant antibody directed against human sperm antigen
AUPQ257199A0 (en) Vaccine antigens of moraxella
AU5632500A (en) Cancer associated antigens and uses therefor

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase